STOCK TITAN

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

PTC Therapeutics (NASDAQ: PTCT) has announced it will host a webcast conference call to discuss its fourth quarter and full year 2024 financial results on Thursday, February 27, at 4:30 p.m. EST. The call will also include updates on the company's business and outlook.

Participants can access the call via phone by registering through a provided link and are advised to dial in 15 minutes before the start time to avoid delays. The webcast will be accessible through PTC's Investor Relations website, with a replay available for 30 days after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.51% News Effect

On the day this news was published, PTCT gained 1.51%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., Feb. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its fourth quarter and full year 2024 financial results and provide an update on the company's business and outlook on Thursday, Feb. 27, at 4:30 p.m. EST.

To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn, and X.

For More Information: 

Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-302375885.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics (PTCT) release Q4 and full year 2024 earnings?

PTC Therapeutics will release its Q4 and full year 2024 earnings on Thursday, February 27, 2025, at 4:30 p.m. EST.

How can investors access PTCT's Q4 2024 earnings call?

Investors can access the call either by phone (requiring pre-registration) or through the webcast on PTC's Investor Relations website at https://ir.ptcbio.com/events-presentations.

How long will PTCT's Q4 2024 earnings call replay be available?

The replay of the earnings call will be available on the company's website for 30 days after the call.

What topics will be covered in PTCT's Q4 2024 earnings call?

The call will cover PTC Therapeutics' fourth quarter and full year 2024 financial results, along with updates on the company's business and outlook.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.17B
78.25M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN